| COVID-19 |
1 |
1 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.63 |
| COVID-19 Vaccine |
0 |
0.98 |
| Immunization |
0 |
0.97 |
| Rheumatic Disease |
0 |
0.99 |
| Otolaryngology |
0 |
0.3 |
| Biologic Therapy |
0 |
0.25 |
| Pain Management |
0 |
0.24 |
| Arthralgia |
0 |
0.22 |
| Pain |
0 |
0.22 |
| Chest Pain |
0 |
0.18 |
| Hospital |
0 |
0.18 |
| Massachusetts |
0 |
0.18 |
| Angina Pectoris |
0 |
0.17 |
| Myalgia |
0 |
0.17 |
| Monoclonal Antibody |
0 |
0.13 |
| Quality of Life |
0 |
0.12 |
| Vaccines |
0 |
0.12 |
| Arthritis |
0 |
0.09 |
| Fatigue |
0 |
0.09 |
| Immunocompromise |
0 |
0.09 |
| Rheumatoid Arthritis |
0 |
0.09 |
| Connective Tissue Disease |
0 |
0.06 |
| Anosmia |
0 |
0.04 |
| Cough |
0 |
0.04 |
| Dentistry and Oral Health |
0 |
0.04 |
| Diarrhea |
0 |
0.04 |
| Diversity |
0 |
0.04 |
| Dysgeusia |
0 |
0.04 |
| Dyspnea |
0 |
0.04 |
| Fever |
0 |
0.04 |
| Glucocorticoid |
0 |
0.04 |
| Headache |
0 |
0.04 |
| Immunology |
0 |
0.04 |
| Lung |
0 |
0.04 |
| Nasal Congestion |
0 |
0.04 |
| Obesity |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |
| Thorax |
0 |
0.04 |
| Tissue |
0 |
0.04 |
| Vasculitis |
0 |
0.04 |